We are live on
!
Find out more
PRC
Pearl River Capital Portfolio holdings
AUM
$630M
1-Year Est. Return
17.08%
This Fund
S&P 500
This Quarter
Est. Return
+20.49%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$149M
(+288%)
Cap. Flow
+$143M
Cap. Flow
% of AUM
71%
Top 10 Holdings %
Top 10 Hldgs %
12.72%
Holding
641
New
154
Increased
108
Reduced
3
Closed
376
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$2.86M |
| 2 |
L3Harris
LHX
|
+$2.73M |
| 3 |
Sempra
SRE
|
+$2.69M |
| 4 |
CME Group
CME
|
+$2.65M |
| 5 |
Global Payments
GPN
|
+$2.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$760K |
| 2 |
American Electric Power
AEP
|
+$752K |
| 3 |
Procter & Gamble
PG
|
+$749K |
| 4 |
Visa
V
|
+$715K |
| 5 |
Electronic Arts
EA
|
+$650K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.17% |
| 2 | Financials | 15.1% |
| 3 | Healthcare | 13.84% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Industrials | 8.88% |
Similar funds
SCM
IFAM
GIM
MCM
AT
AC
PWS
RVPG
Pearl River Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Pearl River Capital held 641 positions worth $201M, up 288% from $51.8M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Pearl River Capital deployed $143M of net new capital in Q2 2020, opening 154 new positions and adding to 108 existing holdings. Its largest new stake was Biogen: 9,509 shares worth $2.54M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Applied Materials, an estimated $458K trimmed.
- Pearl River Capital's largest Q2 2020 buy was Biogen: 9,509 shares worth $2.54M.
- Pearl River Capital added most to L3Harris in Q2 2020, an estimated $2.73M increase.
- Pearl River Capital's biggest Q2 2020 reduction was Applied Materials, cutting an estimated $458K.
- Pearl River Capital fully exited Gilead Sciences in Q2 2020, selling an estimated $760K.
- Pearl River Capital's ten largest holdings make up 13% of its $201M portfolio in Q2 2020.
- Pearl River Capital opened 154 new positions and closed 376 in Q2 2020.
- Pearl River Capital's portfolio value rose 288% quarter-over-quarter to $201M.
Based on Pearl River Capital's 13F filing for Q2 2020, filed 10 Aug 2020.